Package Leaflet: Information for the User
Taioma Plus30mg/15mg prolonged-release tablets EFG
Oxycodone hydrochloride/Naloxone hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Taioma Plus is a prolonged-release tablet, which means that the active substances are released over a longer period of time. Its effect lasts 12 hours.
These tablets are for use in adults only.
Pain relief
You have been prescribed Taioma Plus for the treatment of severe pain, which can only be adequately managed with opioid analgesics. Naloxone hydrochloride is added to counteract constipation.
How these tablets work for pain relief
These tablets contain oxycodone hydrochloride and naloxone hydrochloride as active substances. Oxycodone hydrochloride is responsible for the analgesic effect of Taioma Plus and is a potent analgesic of the opioid group.
The second active substance of Taioma Plus, naloxone hydrochloride, has the function of counteracting constipation. Intestinal dysfunction (e.g. constipation) is a common side effect of treatment with opioid analgesics.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Taioma Plus:
Breathing-related sleep disorders
Taioma Plus may cause breathing-related sleep disorders such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, nighttime awakenings due to difficulty breathing, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else observes these symptoms, consult your doctor. Your doctor may consider reducing the dose.
Tell your doctor if you have had any of these conditions in the past. Also, inform your doctor if you develop any of these conditions during treatment with these tablets.
The most serious consequence of opioid overdose is respiratory depression (slow and shallow breathing). This can also cause a decrease in oxygen concentration in the blood, which can lead to fainting, etc.
Swallow the prolonged-release tablet whole, so that the slow release of oxycodone hydrochloride from the prolonged-release tablet is not affected. Do not break, chew, or crush the tablets. Taking them broken, chewed, or crushed can lead to a potentially fatal overdose of oxycodone hydrochloride (see section 3 "If you take more Taioma Plus than you should").
If you experience severe diarrhea at the start of treatment, it may be due to the effect of naloxone. It can be a sign that bowel function is returning to normal. This diarrhea may occur in the first 3 to 5 days of treatment. If it persists beyond this 3 to 5-day period, or if you are concerned, contact your doctor.
If you have been receiving another opioid, you may experience withdrawal symptoms shortly after starting treatment with Taioma Plus, such as restlessness, sweating, and muscle pain. If you experience any of these symptoms, you may need special monitoring by your doctor.
Tolerance, dependence, and addiction
This medicine contains oxycodone, which is an opioid, and can cause dependence and/or addiction.
This medicine contains oxycodone, which is an opioid medicine. Repeated use of opioid analgesics can make the medicine less effective (you get used to it, which is known as tolerance). Repeated use of Taioma Plus can cause dependence and abuse, which can lead to overdose and put your life at risk. It is essential that you inform your doctor if you think you may have developed dependence on Taioma Plus.
Dependence or addiction can make you feel that you no longer have control over the amount of medicine you need to take or how often you need to take it. You may feel that you need to keep taking the medicine, even when it no longer helps to relieve your pain.
The risk of becoming dependent or addicted varies from person to person. You may have a higher risk of becoming dependent or addicted to Taioma Plus:
If you notice any of the following signs while taking Taioma Plus, it could be a sign that you have become dependent or addicted.
If you notice any of these signs, talk to your doctor to discuss the best treatment for you, including when it is appropriate to stop taking it and how to do so safely (see section 3, "If you stop taking Taioma Plus").
Tell your doctor if you have cancer associated with peritoneal metastasis or initial intestinal obstruction in advanced stages of digestive and pelvic cancers.
If you need to undergo surgery, tell the doctors that you are taking Taioma Plus.
Like other opioids, oxycodone can affect the normal production of hormones in the body, such as cortisol or sex hormones, especially if high doses are taken for long periods. If you notice persistent symptoms such as malaise (including vomiting), loss of appetite, fatigue, weakness, dizziness, changes in menstrual cycle, impotence, infertility, or decreased sexual desire, consult your doctor so that they can monitor your hormone levels.
This medicine may increase your sensitivity to pain, especially at high doses. Inform your doctor if this occurs. It may be necessary to reduce the dose or change the medicine.
You may observe remains of the prolonged-release tablet in your stool. Do not be alarmed, as the active substances (oxycodone hydrochloride and naloxone hydrochloride) have already been released in the stomach and intestine and have been absorbed by your body.
Misuse of Taioma Plus
These tablets are not for the treatment of withdrawal syndrome.
The prolonged-release tablet can be divided into equal doses but must not be chewed or crushed.
Taking the tablets chewed or crushed can lead to a potentially fatal overdose of oxycodone hydrochloride (see section 3 "If you take more Taioma Plus than you should").
Abuse
Never misuse Taioma Plus, especially if you have an addiction to any drug. If you are addicted to substances such as heroin, morphine, or methadone, you are likely to experience severe withdrawal symptoms if you misuse these tablets, as they contain naloxone. They can worsen pre-existing withdrawal symptoms.
Misuse
Never dissolve these tablets to inject them (e.g., into a blood vessel). The reason is that they contain talc, which can cause local tissue destruction (necrosis) and changes in lung tissue (pulmonary granuloma). This abuse can also have other serious consequences and even cause death.
Doping
The use of Taioma Plus can result in positive doping tests. The use of Taioma Plus as a doping agent can endanger health.
Other medicines and Taioma Plus
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
The risk of side effects increases if you use antidepressants (such as citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine). These medicines can interact with oxycodone and may cause symptoms such as involuntary muscle contractions, agitation, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, and body temperature above 38°C. Contact your doctor if you experience these symptoms.
The concomitant use of opioids, including oxycodone hydrochloride, and sedative medicines such as benzodiazepines or related medicines, increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can put your life at risk. Due to this, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes Taioma Plus together with sedative medicines, your doctor should limit the dose and duration of concomitant treatment.
Tell your doctor about all sedative medicines you are taking and follow your doctor's recommended doses carefully. It may be useful to inform friends or family members who are aware of the signs and symptoms indicated above. Contact your doctor when you experience these symptoms. Some examples of sedative medicines or related medicines are:
No interactions are expected between Taioma Plus and paracetamol, acetylsalicylic acid, or naltrexone.
Using Taioma Plus with food, drinks, and alcohol
Drinking alcohol while taking Taioma Plus can make you feel more drowsy or increase the risk of serious side effects such as shallow breathing with the risk of stopping breathing, and loss of consciousness. It is recommended not to drink alcohol while taking Taioma Plus.
You should avoid drinking grapefruit juice while taking Taioma Plus.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
During pregnancy, these tablets should be avoided as much as possible. If used during prolonged periods of pregnancy, oxycodone hydrochloride may cause withdrawal symptoms in the newborn. If oxycodone hydrochloride is administered during labor, the newborn may experience respiratory depression (slow and shallow breathing).
Breastfeeding
Breastfeeding should be discontinued during treatment with these tablets. Oxycodone hydrochloride passes into breast milk. It is not known if naloxone hydrochloride also passes into breast milk. Therefore, the risk to the breastfed child cannot be excluded, especially if the mother receives multiple doses of Taioma Plus.
Driving and using machines
Taioma Plus can affect your ability to drive and use machines. This is especially true at the start of treatment with Taioma Plus, after a dose increase, or after switching from another medicine. However, these side effects disappear once you take a stable dose of Taioma Plus.
Taioma Plus has been associated with drowsiness and sudden sleep episodes. If you experience these side effects, do not drive or use machinery. If this happens, inform your doctor.
Consult your doctor if you are allowed to drive or use machines.
Before starting treatment and periodically during treatment, your doctor will discuss with you what you can expect from the use of Taioma Plus, when and for how long you should take it, when to contact your doctor, and when you should stop taking it (see also "If you stop treatment with Taioma Plus").
Taioma Plus is a prolonged-release tablet, which means that the active ingredients are released over a prolonged period. Its action lasts 12 hours.
You should swallow the prolonged-release tablet whole to avoid affecting the slow release of oxycodone hydrochloride from the tablet. Do not break, crush, or chew the tablets. If you do, your body may absorb a potentially fatal dose of oxycodone hydrochloride (see section 3 "If you take more Taioma Plus than you should").
Unless your doctor tells you otherwise, theusual dose is:
For pain treatment
Adults
The usual initial dose is 10 mg of oxycodone hydrochloride / 5 mg of naloxone hydrochloride in prolonged-release tablets every 12 hours.
Your doctor will decide the dose you should take per day and how to divide it into morning and evening doses. Your doctor will also decide if it is necessary to adjust the dose during treatment. Your dose will be adapted to your degree of pain and individual sensitivity. You should receive the minimum necessary dose to relieve pain. If you have already received treatment with opioids, the initial dose of Taioma Plus may be higher.
The maximum daily dose is 160 mg of oxycodone hydrochloride and 80 mg of naloxone hydrochloride. If you need a higher dose, your doctor may prescribe more oxycodone hydrochloride without naloxone hydrochloride. However, the maximum daily dose of oxycodone hydrochloride should not exceed 400 mg. The beneficial effect of naloxone hydrochloride on intestinal activity may be affected if the dose of oxycodone hydrochloride is increased without increasing the dose of naloxone hydrochloride.
If you replace these tablets with another opioid analgesic, your intestinal function may worsen.
If you experience pain between two doses of Taioma Plus, you may need a fast-acting analgesic. Taioma Plus is not suitable for treatment in this case. For these cases, consult your doctor.
If you feel that the effect of these tablets is too strong or too weak, consult your doctor or pharmacist.
Elderly patients
In general, it is not necessary to adjust the dose in elderly patients with normal kidney and/or liver function.
Liver or kidney disorder
If you have kidney disorder of any degree or mild liver disorder, your doctor will prescribe these tablets with special caution. If you have moderate or severe liver disorder, you should not take these tablets (see also section 2 "Do not take Taioma Plus" and "Warnings and precautions").
Children and adolescents under 18years
Taioma Plus has not been studied in children and adolescents under 18 years. Its safety and efficacy have not been demonstrated in these patients. For this reason, the use of Taioma Plus is not recommended in children and adolescents under 18 years.
Method of administration
Oral.
Take these tablets every 12 hours, following a fixed schedule (e.g., at 8 am and 8 pm).
Swallow these tablets with sufficient liquid (half a glass of water). The tablet can be divided into two equal doses. Donot break, chew, or crush the tablets. You can take the prolonged-release tablets with or without food.
Duration of treatment
In general, you should not take these tablets for longer than necessary. If you receive these tablets for a long time, your doctor should regularly check that you still need them.
If you take more Taioma Plusthan you should
If you have taken more tablets than prescribed, you should inform your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount used. It is recommended to take the medication package and leaflet to the healthcare professional.
An overdose can cause:
In severe cases, loss of consciousness (coma), fluid accumulation in the lungs, and circulatory collapse may occur, which can be fatal in some cases.
You should avoid situations that require a high level of alertness, such as driving.
If you forget to take Taioma Plus
Oif you take a lower dose than prescribed, you may stop noticing the analgesic effect.
If you forget to take a dose, follow these instructions:
Do not take a double dose to make up for forgotten doses.
If you stop treatment with Taioma Plus
Do not stop treatment without consulting your doctor.
If you no longer need treatment, you should gradually reduce the daily dose, after discussing it with your doctor. This will help you avoid withdrawal symptoms, such as restlessness, sweating, and muscle pain.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Important side effects or signs to consider, and what to do if you experience them:
If you already have any of the following important side effects, consult your doctor immediately.
Slow and shallow breathing (respiratory depression) is the main danger of opioid overdose. It occurs mainly in elderly and debilitated patients. Opioids can also cause a significant decrease in blood pressure in susceptible patients.
The following side effects have been observed in patients for pain treatment:
Common(may affect up to 1 in 10 patients):
|
|
|
|
|
|
|
|
|
|
"everything is spinning" |
|
|
|
|
|
|
|
|
|
Uncommon (may affect up to 1 in 100 people):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |
|
| |
| ||
| ||
|
Rare (may affect up to 1 in 1,000 people):
|
|
|
|
|
Frequency not known (frequency cannot be estimated from available data):
|
|
|
|
|
|
|
|
|
|
|
It is known that the active ingredient oxycodone hydrochloride, if not combined with naloxone hydrochloride, has the following side effects, different from those mentioned:
Oxycodone may cause respiratory problems (respiratory depression), decreased pupil size, muscle spasms of the bronchial and smooth muscles, and depression of the cough reflex.
Common (may affect up to 1 in 10 people):
|
|
|
|
|
Uncommon (may affect up to 1 in 100 people):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rare (may affect up to 1 in 1,000 people):
|
|
|
|
|
Frequency not known (frequency cannot be estimated from available data):
|
|
|
|
|
|
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children. Store this medication in a safe and closed place, where others cannot access it. It can cause serious harm and be fatal to people who have not been prescribed it.
Do not use this medication after the expiration date shown on the box and blister pack, after "EXP". The expiration date is the last day of the month indicated.
Blister pack: Do not store above 25°C.
Bottles: Do not store above 30°C. Validity period after first opening: 3 months.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofTaioma Plus
The active ingredients are: oxycodone hydrochloride and naloxone hydrochloride.
Each prolonged-release tablet contains 30 mg of oxycodone hydrochloride (equivalent to 27 mg of oxycodone) and 15 mg of naloxone hydrochloride (as 16.35 mg of naloxone hydrochloride dihydrate, equivalent to 13.5 mg of naloxone).
The other ingredients are:
Tablet core: Polyvinyl acetate, Povidone K30, sodium lauryl sulfate, colloidal silicon dioxide, microcrystalline cellulose, and magnesium stearate.
Tablet coating: Polyvinyl alcohol, titanium dioxide (E171), yellow iron oxide (E172), macrogol 3350, and talc.
Appearance of Taioma Plus and package contents
Prolonged-release tablets are yellow, oblong, biconvex, with break lines on both sides, with a length of 12.2 mm, width 5.7 mm, and height of 3.3 - 4.3 mm.
The tablet can be divided into two equal doses.
Taioma Plus is available in:
Child-resistant blister packs of 10, 14, 20, 28, 30, 50, 56, 60, 98, and 100 prolonged-release tablets or bottles with child-resistant caps of 50, 100, and 250 prolonged-release tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
Manufacturer
Develco Pharma GmbH
Grienmatt 27, Schopfheim
79650
Germany
This medication is authorized in the Member States of the European Economic Area under the following names:
Germany | Oxycodon comp. EVER Pharma 30 mg/15 mg Retardtabletten |
Spain | Taioma Plus 30 mg/15 mg prolonged-release tabletsEFG |
Date of last revision of this leaflet: March 2025
"Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/ "
The average price of TAIOMA PLUS 30 mg/15 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 76.15 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.